Comparison of the Frequencies of Chronic Obstructive Lung Disease and Asthma Cases Who Applied to the Tertiary Hospital Before the COVID-19 Pandemic and during the COVID-19 Pandemic Period

Abstract

Aim: In December 2019, a new coronavirus agent was detected in the research conducted on the reporting of viral pneumonia cases of unknown cause in Wuhan, China. Chronic diseases have prepared a ground that increases the effects of the epidemic with the COVID-19 epidemic. This study was carried out to determine whether there is a statistically significant difference between the frequencies of COPD and Asthma cases, who applied to the hospital before the COVID-19 pandemic and during the COVID-19 pandemic period. Material and methods: COPD and Asthma patients who applied to the emergency service, outpatient clinics and services of the hospital during the pre-COVID-19 pandemic period and the COVID-19 pandemic period were included in the study. Demographic data of the cases included in the study and COPD and asthma cases were statistically analyzed separately, both on the total cases of COPD and Asthma, according to the pre-pandemic period and the pandemic period. Results: According to the results, the number of COPD and asthma admitted to the hospital during the COVID-19 pandemic period was found to be statistically significantly lower than the number of COPD and asthma admitted to the hospital in the pre-COPD-19 pandemic period. (p<0,05). The effect of air quality level on COPD and Asthma incidence rates was evaluated in the Pre-Pandemic and pandemic periods. During the pandemic period, it was determined that there was an increase in air quality compared to the pre-pandemic period. Conclusion: It can be said that the general and personal precautions taken during the COVID-19 pandemic period cause a decrease in the admission of COPD and Asthma patients to the hospital.

Keywords

• COVID-19
• Pandemic
• Chronic Obstructive Pulmonary Disease
• Asthma

COVID-19 Pandemi Öncesi ve COVID-19 Pandemi Döneminde 3. Basamak Sağlık Kuruluşuna Başvuran Kişilerde Kronik Obstrüktif Akciğer Hastalığı ve Astım Vakalarının Sıklıklarının Karşılaştırılması

Abstract

Amaç: Aralık 2019’da Çin’in Wuhan şehrinde nedeni bilinmeyen viral pnömoni olgularının bildirilmesi üzerine yapılan araştırmalarda yeni bir Koronavirüs etkeni saptanmıştır. Kronik hastalıklar, COVID-19 salgını ile salgının etkilerini arttıran bir zemin hazırlamıştır. Bu araştırma COVID-19 pandemi öncesi ve COVID-19 pandemi döneminde hastaneye başvuran kişilerde, Kronik Obstrüktif Akciğer Hastalığı (KOAH) ve astım vakalarının sıklıkları arasında istatistiksel olarak anlamlı bir fark olup olmadığının saptanması amacıyla yapılmıştır. Gereç ve Yöntemler: Çalışmaya COVID-19 pandemi öncesi dönem ile COVID-19 pandemi döneminde hastanenin acil servis, poliklinikler ve servislerine başvuran KOAH ve astım hastaları alındı. Çalışmaya dahil edilen vakaların demografik verileri ile KOAH ve astım vakaları, pandemi öncesi dönem ile pandemi dönemine göre hem KOAH ve hem de astım toplam vakaları üzerinden hem de ayrı ayrı istatistiksel olarak analiz edildi. Pandemi öncesi ve pandemi döneminde hava kalite düzeyinin, KOAH ve astım vaka sıklıkları üzerine etkisi değerlendirildi. Bulgular: Elde edilen sonuçlara göre, COVID-19 pandemi dönemindeki hastaneye başvuran KOAH ve astım sayısı, COVID-19 pandemi öncesi dönemdeki hastaneye başvuran KOAH ve astım sayısından istatistiksel olarak anlamlı olarak daha düşük bulundu (p<0,05). Pandemi öncesi ve pandemi döneminde hava kalite düzeyinin, KOAH ve astım vaka sıklıkları üzerine etkisi değerlendirildi. Pandemi döneminde, pandemi öncesine göre hava kalitesinde artış olduğu saptandı. Sonuç: COVID-19 pandemi döneminde alınan genel ve kişisel önlemlerin KOAH ve astım hastalarının hastaneye başvurmasında azalmaya neden olduğu söylenebilir.

Keywords

• COVID-19
• Pandemi
• Kronik Obstrüktif Akciğer Hastalığı
• Astım

References

1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. [Cited: 2021 August 20. Available from: https://coronavirus.jhu.edu/map.html.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020; 395: 497-06.
3. WHO Coronavirus (COVID-19 Dashboard [Internet]. [Cited: 2022 October 03. Available from: https://COVID-19.who.int.
4. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic ıntervention for coronavirus disease-19. Asian Pas J Alergy Immunol. 2020; 38(1): 10-8.
5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395(10223): 507-13.
6. Organization WH. Noncommunicable diseases [Internet]. [Cİted: 2021 August 20. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
7. Global Strategy for Diagnosis, Management and Prevention of COPD. The Global Initiative for Chronic Obstructive Lung Diseases (GOLD) 2020 report [Internet]. [Cİted: 2021 August 20. Available from: https://goldcopd.org/gold-reports/.
8. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 10.1111/all.14238. 94 14.

9. Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020; 10.1111/all.14289.
10. Global Initiatives for Asthma. Global Strategy for Asthma Management and Prevention 2020 [Internet]. [Cİted: 2021 August 15. Available from: www.ginasthma.org/.
11. State Of Global Air, A Special Report on Global Exposure To Air Pollution and its Disease Burden, 2019 [Internet]. [Cİted: 2021 August 16. Available from: https://www.stateofglobalair.org/sites/default/ files/soga_2019_report.pdf/.
12. Grgic S, Skocibusic S, Celjuska-Tosev E, Nikolic J, Arapovic J, Kuzman I. Different features of influenza A H1N1pdm09 virus infection among adults in 2009/10 and 2010/11. J Infect Dev Ctries. 2016; 10(2): 155-62.
13. Nakada LYK, Urban RC. COVID-19 pandemic: Impacts on the airquality during the partial lock down in São Paulo state, Brazil. Science of the Total Environment. 2020; 730: 139087
14. COVID-19 Air Quality Report,22 [Internet]. [Cİted: 2021 August 24. Available from: https://www.iqair.com.
15. Wu J, Xu F, Zhou W, Feikin D, Lin C, He X et al. Risk Factors For SARS Among Persons Without Known Contact With SARS Patients, Beijing, China. Emerg Infect Dis. 2004; 10(2): 210-6.
16. Akyüz E, Üner A, Köklü B, Polat K, Eroğlu E, Küllü I, ve ark [Internet]. Ülkemizdeki kronik hastalığı bulunan bireylerin korona-virüs salgınından korunma tedbirlerine uymaması. [Cited: 2021 May 11. Available from: https://COVID-19.tubitak.gov.tr/sites/default/files/docs/2020-03/akyuz-et-al.-korona-makalesi.pdf .
17. Martin-Loeches I, Vidaur E, Torres A, Laborda C, Granada R, Bonastre J, et al. Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients. Crit Care. 2011; 15(6): R286.
18. Sinha P, Reifler K, Rossi M, Sagar M. Coronavirus Disease 2019 mitigation strategies were associated with decreases in other respiratory virus infections. Open Forum Infectious Diseases. 2021; 8(6)ofab 105. https://doi.org/10.1093/ofid/ofab105.
19. Zhang JJ, Dong X, Cao YY, Yuan Y, Yang Y, Yan Y et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7): 1730-41.
20. Zhang JJ, Cao YY, Dong X, Wang BC, Liao MY, Lin J, et al. Distinct characteristics of COVID-19 patients with initial rRT-PCR positive and negative results for SARS- CoV-2. Allergy. 2020; 75(7): 1809-12.
21. Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (15): 458-64.
22. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N et all. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020; 92(10): 1915-21.
23. The Lancet Respiratory Medicine. Reflecting on World Asthma Day in the era of COVID-19. Lancet Respir Med. 2020; 8(5): 423.
24. Bhutani M, Hernandez P, Bourbeau J, Dechman G, Penz E, Aceron R, et al. Key highlights of the Canadian Thoracic Society’s position statement on the optimization of chronic obstructive pulmonary disease management during the COVID-19 pandemic. Chest. 2020; 158(3): 869-72.